Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries (NY: ELV ) 545.96 +2.64 (+0.49%) Official Closing Price Updated: 7:00 PM EDT, Aug 23, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about ELV < Previous 1 2 3 4 5 6 7 8 9 10 Next > Evolent Health Explores Sale, Garners Inbound Interest From Private Equity Firms August 23, 2024 Evolent Health is exploring a potential sale, drawing interest from private equity firms like TPG and KKR. Via Benzinga Here's How Much $1000 Invested In Elevance Health 10 Years Ago Would Be Worth Today August 22, 2024 Via Benzinga Looking At Elevance Health's Recent Unusual Options Activity August 20, 2024 Via Benzinga 10 Health Care Stocks Whale Activity In Today's Session August 19, 2024 Via Benzinga What Analysts Are Saying About Elevance Health Stock August 19, 2024 Via Benzinga 'An Irrelevant Company': Jim Cramer Says Snap Is 'Not Investable' August 13, 2024 Jim Cramer suggests buying Applied Materials despite government concerns, Aflac not favored, UnitedHealth Group best, Snap not investable. Via Benzinga $1000 Invested In This Stock 20 Years Ago Would Be Worth $13,000 Today August 07, 2024 Via Benzinga If You Invested $1000 In This Stock 15 Years Ago, You Would Have $10,000 Today July 25, 2024 Via Benzinga 10 Health Care Stocks With Whale Alerts In Today's Session August 12, 2024 Via Benzinga Elevance Health’s Whole Health Index Demonstrates Opportunity to Improve Health August 12, 2024 From Elevance Health, Inc. Via Business Wire Elevance Health Teams Up with the Impact Fitness Foundation to Support Irvington Preparatory Academy July 31, 2024 From Elevance Health, Inc. Via Business Wire Leading Healthcare Provider Stock Soars on Earnings Beat July 26, 2024 Molina Healthcare's Q2 earnings and strategic acquisitions fuel a surge in its stock price, signaling the potential for continued growth. Via MarketBeat Topics Earnings Exposures Financial How Is The Market Feeling About Elevance Health? July 23, 2024 Via Benzinga A Closer Look at Elevance Health's Options Market Dynamics July 18, 2024 Via Benzinga Is This Telehealth Stock a Buy After the Recent Pullback? July 19, 2024 Hims & Hers Health leverages telehealth's accessibility to disrupt traditional healthcare and deliver personalized wellness solutions. Via MarketBeat BofA Downgrades Elevance Health On Medicaid Pressure And Lowered Peer Valuations July 18, 2024 Elevance Health reports Q2 revenues of $43.2 billion, slightly above consensus despite a 0.4% YoY decline driven by Medicaid membership attrition. Analysts express concerns over ongoing Medicaid margin... Via Benzinga Healthcare Investors Bet On Easier Medicare Rules Under Potential Trump Administration July 17, 2024 Investors expect Trump to ease Medicare Advantage regulations if he wins another term. This could lead to renewed merger talks among health insurers. Via Benzinga Topics Government Exposures Political Nasdaq 100 Suffers Worst Day In 11 Months As Chipmakers Tumble On China Curbs; Magnificent 7 Wipe Out $500B : What's Driving Markets Wednesday? July 17, 2024 It’s deep red on Wall Street on Wednesday, with tech stocks sharply falling amid a semiconductor broad-based selloff following news that the Biden administration is hastening export restrictions to... Via Benzinga Elevance Health (ELV) Q2 2024 Earnings Call Transcript July 17, 2024 ELV earnings call for the period ending June 30, 2024. Via The Motley Fool Topics Earnings Exposures Financial Elevance Health Beat Street Estimates On Q2 Profit And Revenue, Sticks To Annual Guidance July 17, 2024 Elevance Health surpasses Q2 profit and revenue estimates, reporting $43.2 billion in revenue and $2.3 billion in profit. Despite a 5% decline in medical membership due to Medicaid attrition, premium... Via Benzinga Elevance Health Reports Second Quarter 2024 Results July 17, 2024 From Elevance Health, Inc. Via Business Wire Evaluating Elevance Health: Insights From 15 Financial Analysts July 15, 2024 Via Benzinga 3 Stocks to Buy From the ‘Ultimate’ Buy-and-Hold Portfolio July 08, 2024 Finding stocks to buy and hold for the long haul is sometimes as easy as grabbing a few suggestions from a seasoned investment pro. Via InvestorPlace If You Invested $100 In This Stock 15 Years Ago, You Would Have $1,100 Today July 08, 2024 Via Benzinga 16 Analysts Have This To Say About Elevance Health June 24, 2024 Via Benzinga Elevance Health Releases Impact Report July 08, 2024 From Elevance Health, Inc. Via Business Wire Tame Volatility With These 3 Low Beta Stocks July 06, 2024 Beta measures a stock's volatility in comparison to the overall market. Three low-beta stocks could all be considered for those looking for a more conservative approach. Via Talk Markets Elevance Stock Elevated On Excellent Marketing Execution June 27, 2024 Elevance stock boasts a 92 EPS Rating out of 99. It has an 86 Composite Rating and a B+ Accumulation/Distribution Rating. Via Investor's Business Daily Elevance Health to Hold Conference Call and Webcast to Discuss Second Quarter 2024 Results on July 17, 2024 June 26, 2024 From Elevance Health, Inc. Via Business Wire Morgan Stanley Says Elevance Health's Growth Attributed To Consistent Performance But Undervalued June 24, 2024 Morgan Stanley initiates coverage on Elevance Health with an Overweight rating and a $643 price target. Elevance Health's diversified offerings and growth potential in Medicare Advantage, PBM,... Via Benzinga < Previous 1 2 3 4 5 6 7 8 9 10 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.